174 Does addition of erythropoietic stimulating agents...

Leukemia Research 2011 Vol. 35; Iss. supp-S1

174 Does addition of erythropoietic stimulating agents (ESAs) improve the outcome of higher-risk MDS patients treated with azacitidine (AZA)?

R. Itzykson, S. Thepot, O. Beyne-Rauzy, S. Ame, F. Isnard, C. Salanoubat, A.-L. Taksin, Y. Chelgoum, B. Quesnel, J.-V. Malfuson, L. Legros, N. Vey, P. Turlure, C. Gardin, S. Boehrer, L. Ades, P. Fenau
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
35
Year:
2011
Language:
english
Pages:
1
DOI:
10.1016/s0145-2126(11)70176-x
File:
PDF, 58 KB
english, 2011
Conversion to is in progress
Conversion to is failed